CSF1R and Alzheimer disease: CSF1R signaling on microglia has been shown to interact with the TREM2 receptor, a protein linked to increased risk for developing AD, indicating a mechanism by which CSF1R may serve as a target for therapeutic intervention in AD (Cheng et al., 2021; Van Lengerich et al., 2023).